Everolimus and bevacizumab for advanced papillary kidney cancer
In this phase 2 clinical trial, a combination of everolimus [...]
The role of radiation therapy in kidney cancer
Dr Hans Hammers from the University of Texas Southwestern Medical [...]
ENTRATA study of telaglenastat in combination with everolimus in patients with kidney cancer
In this video interview Dr Chung-Han Lee from Memorial Sloan [...]
New survival data for pembrolizumab plus axitinib in advanced kidney cancer
A paper published in The Lancet Oncology this month provides [...]
Cancer52: Access to data for rare and less common cancers
Sharon Kell attending this meeting with Cancer52 members to discuss [...]
Access to Cancer Medicines Coalition
The first Access to Cancer Medicines (ACMC) meeting since December [...]
Cancer52: CEO Meeting
Sharon Kell took Rose Woodward's place at the Cancer52 Chief [...]
ABPI Patient Organisation Forum
Sharon Kell rang in to this interesting virtual meeting of [...]
ABPI Patient Organisation Forum: NICE methods and processes review
KCSN is a member of the Association of the British Pharmaceutical [...]
Safety and efficacy of tivozanib–nivolumab combination in patients with metastatic kidney cancer
In this phase 1b/2 study the researchers looked at a [...]
